The European Commission would like greater use of joint assessments focusing on the effectiveness of new medicines and medical devices in comparison to existing products. In a draft regulation presented on 31 January, it proposed that they carry out joint Health Technology Assessments at a European level (see EUROPE 11942). All member states will have to participate after a six-year transition period.
Health Technology Assessments (HTA) form part of a multidisciplinary process that provides...